0.00Open0.00Pre Close0 Volume0 Open Interest27.00Strike Price0.00Turnover259.65%IV-56.16%PremiumDec 20, 2024Expiry Date9.71Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8776Delta0.0353Gamma1.73Leverage Ratio-0.0906Theta-0.0034Rho-1.52Eff Leverage0.0045Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet